Stay updated on Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page displays the study record for a trial combining pembrolizumab with stereotactic radiosurgery for metastatic breast cancer, including eligibility criteria, recruiting locations, study design, and outcome measures.
    Difference
    49%
    Check dated 2026-11-07T13:55:30.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:33:07.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A new NIH-wide notice announces website-transition updates and says NIH content may use “Super Intelligence” alongside “Artificial Intelligence.” The study page still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-24T15:59:26.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.1 to v3.7.2. The study record page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T15:55:11.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site footer revision indicator changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:48:54.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content with an access-restricted message. This indicates an access issue rather than an update to the study record.
    Difference
    18%
    Check dated 2026-09-19T18:10:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.